2 unknown, 1 completed. 2 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Jesper Ekelund: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Famotidine in Schizophrenia Famotidine, Placebo - Schizophrenia | Phase 2 / Phase 3 | Unknown | Jesper Ekelund | 140 | 2014-03-01 | 2015-04-14 |
| Sequence Towards Remission in Depression escitalopram 10 mg, Placebo - Depression | Phase 4 | Unknown | Jesper Ekelund | 90 | 2012-06-01 | 2012-06-27 |
| Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia famotidine, Placebo (Microcrystallized cellulose) - Schizophrenia | Phase 4 | Completed | Jesper Ekelund | 30 | 2008-01-01 | 2012-03-20 |
Schizophrenia (2) · Bronchiolitis Obliterans Syndrome (1) · Depression (1)
Famotidine (2) · Escitalopram (1)
Finland (3) · Sweden (1)